Position in ACET
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$196,810
+$41,686 QoQ
Shares Held
22,779
0.0% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#33
of 56 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JOHNSON & JOHNSON holds $757,781,542 across 11 Biotechnology names. ACET ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
2,449,183 | $300,220,852 | |
| 2 | NBTX |
Nanobiotix S.A.
|
5,623,816 | $212,017,863 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
6,641,064 | $89,720,774 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
1,784,517 | $74,360,823 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
1,979,173 | $32,438,645 | |
| 6 | LEGN |
Legend Biotech Corp
|
814,586 | $23,525,243 | |
| 7 | XNCR |
Xencor Inc
|
748,062 | $12,043,798 | |
| 8 | FATE |
Fate Therapeutics Inc
|
3,379,064 | $9,123,472 |
All Filings in ACET
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,810 | 22,779 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $155,124 | 22,779 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $191,799 | 22,779 | Shares | Defined | 2026-03-18 | |
| 2025-09-30 | $295,222 | 364,472 | Shares | Defined | 2026-03-18 | |
| 2025-06-30 | $222,327 | 364,472 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $275,176 | 364,472 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $350,622 | 364,472 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $524,839 | 364,472 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $441,011 | 364,472 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $856,509 | 364,472 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,301,444 | 688,595 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $998,653 | 728,944 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,771,333 | 728,944 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $4,198,717 | 728,944 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,516,759 | 728,944 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $10,365,583 | 728,944 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $10,642,582 | 728,944 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $14,557,011 | 728,944 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $12,749,230 | 728,944 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,714,920 | 728,944 | Shares | Defined | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||